AMENDMENT TO AGREEMENTAmendment to Agreement • March 18th, 2016 • Sarissa Capital Management LP • Biological products, (no disgnostic substances)
This AMENDMENT (the “Amendment”) is made as of March 17, 2016, by and among ARIAD Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the entities listed on Schedule A hereto (collectively, the “Sarissa Group”).
